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ABSTRACT 
Objective:  To evaluate the frequency of improved visual acuity after Endoscopic Endonasal Transsphenoidal 
excision of pituitary gland tumor. 
Study Design:  Descriptive case series. 
Materials and Methods:  In our study, Pre-operative visual acuity was noted by using the Snellen’s chart. Then 
patients underwent pituitary gland excision though Endoscopic Endonasal Transsphenoidal approach under 
general anesthesia. After surgery, patients were shifted in postsurgical wards and then will be discharged from 
there and were examinedfor 3 months in OPD. Snellen’s chart was used to evaluate patents for visual acuity after 
3 months by an experienced ophthalmologist having at least 4 years residency experience If visual acuity 
increased ≥ 1 line, then improved visual acuity was labeled. 
Results:  Improved visual acuity after pituitary gland tumor excision was seen in 59(89.39%) patients. Age and 
gender of patients did not show any statistically significant association for improved visual acuity. 
Conclusions:  Results of this study showed that pituitary gland tumor excision through Endoscopic Endonasal 
Transsphenoidal approach is effective in terms of visual acuity improvement. Our main objectives in pituitary 
surgery are protection and reinstatement of vision and this surgical approach give maximum cover to vision 
restoration. 
Keywords:  Transsphenoidal excision, Pituitary adenoma, Visual acuity. 
 
INTRODUCTION 
Giant pituitary adenomas of fibrous consistency, 
excessive size and unfavorable geometric 
configuration can be difficult to resect through 
conventional operative approaches.1 
 Frequency of 16.7% pituitary adenomas was 
documented covering various groups of brain 
tumors.Pituitary tumors are believed to be of benign 
nature histologically. Though, these adenomas may 
increase in size leading to neurosurgical complications 
such as visual impairment and if not treated timely it 
may lead to blindness.2,3 
 In resection of giant pituitary adenomas, additional 
visualization of critical neurovascular structures can be 
achieved by using a transcranial component to the 
Transsphenoidal approach. The rates of complications 
are alike to other series of approaches used to resect 
complicated pituitary tumors. The above and below 
method is secure as well successful and the instant and 
long-lasting benefits of a single-stage approach 
validate its efficacy in this chosen group of patients.1 
 For the elimination of pituitary adenomas, 
Endoscopic Transsphenoidal pituitary surgery is 
becoming more popular. It is also widely recognized 
that Transsphenoidal microscopic/endoscopicresection 
of pituitary adenomas is broadly accepted as a well-
established procedure that provide better results.4 
 5 (16.1%) and 26 (83.9%) out of 31 eyes were
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reported having normal and abnormal pre-operative 
visual fields respectively and 22 out of these 26 were 
improved.5 Another study illustrated that as a result of 
Transsphenoidal surgery, an overall betterment of 78% 
in visual symptoms was recorded.6 
 
MATERIALS AND METHODS 
Study Design 
This Non-probability, consecutive sampling 
techniquestudy was conducted at Neurosurgery 
department, PGMI, Lahore and Khyber Medical 
University, Kohat Institute of Medical Sciences, Kohat 
from September 2017 to October 2018 with a total 
duration of one year. Sixty six patients of ages 
between 20 to 70 years of both genders were taken in 
this study. 
 
Inclusion Criteria 
Patients of either gender and age in 20 to 70 years 
range presenting with diagnosis of pituitary adenoma 
(as per medical record) with visual acuity >20/20 on 
Snellen’s chart. 
 Total 66 patients satisfying inclusion criterion 
were included from OPD of Neurosurgery, Lahore 
General Hospital, Lahore and Khyber Medical 
University, Kohat Institute of Medical Sciences, 
Kohat. 
 
Exclusion Criteria 
Patients with redo surgery or recurrent adenomas (on 
medical record), having congenital or chronic poor 
visual acuity before diagnosis of adenoma (medical 
record). 
 
Data Collection 
Informed consent was obtained. Demographic 
variables (name, age, gender, and duration of 
diagnosis) were also documented. Pre-operative visual 
acuity was noted by using the Snellen’s chart. Then 
patients underwent pituitary gland excision though 
Endoscopic Endonasal Transsphenoidal approach 
under general anesthesia. After surgery, patients were 
shifted in postsurgical wards and then will be 
discharged from there and were examined for 3 
months in OPD. Visual acuity was evaluated by using 
the Snellen’s chart after months by an experienced 
ophthalmologist having at least 4 years residency 
experience. Improvement in Visual acuity was noted if 
visual acuity increased ≥ 1 line. Information was 
collected by using prearranged proforma. 
 
Data Analysis 
Data was analyzed was SPSS Version 20 and 
presented in the form of charts and graphs. 
 
RESULTS 
This study was consisted on 66 patients taken in by 
using Non-probability, Consecutive sampling 
technique. 
 
Gender Distribution 
There were 34 (51.52%) male and 32 (48.48%) female 
patients. 
 
Age Incidence 
Patient’s age was ranging from 20-years to 70-years 
with a mean of 46.26 ± 15.46. Mean duration for 
diagnosis of patients was 6.33 ± 3.13 months. 
 
Clinical Presentation and Treatment 
Visual acuity of patients before and after operation 
was noted. Improved visual acuity after pituitary gland 
tumor excision was seen in 59 (89.39%) patients (Fig. 
1). 
 
 
Fig. 1:  Post-Excision Improvement in VA 
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Outcome 
No statistically significant association was seen 
between age groups and improvement in VA after 
pituitary gland tumor excision (i.e. p-value = 0.857). 
No statistically significant association was seen 
between gender of patients and improvement in VA 
after pituitary gland tumor excision (i.e. p-value = 
0.265). Duration of diagnosis of patients had no 
statistically significant effect on improvement in VA 
after pituitary gland tumor excision (i.e. p-value = 
0.802). Preoperative VA had no significant effect on 
improvement in VA after pituitary gland tumor 
excision (i.e. p-value = 0.120). 
 
DISCUSSSION 
Pituitary adenomas accounts for 10-12% ofall brain 
tumors. Despite its benign nature, the mass effect on 
the optic chiasm and surrounding structures and the 
endocrinological impairment needs prompt and 
adequate treatment of brain tumors. Due to the benefits 
of being minimally invasive and providing direct 
approach to the pituitary gland, surgical removal by 
Endoscopic Endonasal Trans-sphenoidal route is more 
favored treatment. Several factors like the age, the 
preoperative visual impairment, the duration of the 
visual symptoms, the size of the lesion did not 
influence the visual outcome following excision.7,8 
Ourkey goals in pituitary surgery are conservation and 
restoration of vision. 
 Visual disturbances are noted when the PA grows 
superiorly ahead of the sella and squeezes optic nerves 
anteriorly, the optic chiasm centrally, or optic tracts 
posteriorly. The classic presentation is a slowly 
progressive bitemporal hemianopia caused by pressure 
on nasal fibers of the chiasm. Bilateral deterioration of 
central visual acuity is a relatively insensitive indicator 
of mass effect and correlates poorly with visual deficit. 
However, reduced color vision is usually one of the 
first signs of compressive optic neuropathy.9 
 An abrupt hemorrhage or infarction or both within 
the pituitary adenoma causes pituitary apoplexy 
thatnormally comes with impulsivebeginning of 
extreme headache and visual disturbance. Besides 
visual loss, ophthalmologic symptoms often include 
diplopia due to lateral compression of cranial nerves in 
the cavernous sinus. Unstable or progressive visual 
deterioration is an indication for urgent 
Transsphenoidal decompression and tumor removal.10 
 In this study improved visual acuity after pituitary 
gland tumor excision was seen in 59(89.39%) patients. 
Age and gender of patients did not show any 
statistically significant association for improved visual 
acuity. However, in the younger age group number of 
patients was higher as compared to other age groups 
who had improved visual acuity. For both male and 
female patients almost equal number of patients had 
improved visual acuity.Duration of disease and pre-
operative visuals acuity both did not show any 
statistically significant association for improvement in 
visual acuity post operatively. Successful 
Transsphenoidal surgery for PA usually improve 
visual deterioration or even restore it to normal. And 
there is a strong correlation between improvement of 
visual clarity and visual field recovery, but outcomes 
are not parallel in every case. 
 VA of 15/18(83.33%) patients with pituitary 
apoplexy had improved after early Endoscopic 
Transsphenoidal operation reported by Ju-Wan Seuk 
in his study.11 Amit Kumar Thotakura in his study 
reported that 42.2% of patients who underwent 
Transsphenoidal excision of pituitary tumor has 
improved visual acuity but not normalized.12 Recently 
in 2016 Edson Rocha Constantino reported that for the 
cure of large pituitary tumors, visual outcome of 
32.1% of patients improved who were operated by 
endoscopic endonasal Transsphenoidal approach. 
 Our objectives in pituitary adenoma surgery is to 
prevent or stop progression of visual loss. In addition, 
patients who already lost vision from these tumors can 
even achieve recovery following surgery. In literature 
reviews visual improvement after endoscopic 
endonasal Transphenoidal approach for large and giant 
pituitary adenomas excision ranges in between 32.1%-
97.7%13-20 respectively showing better results of 
endoscopic endonasal Transphenoidal approach for 
management of pituitary tumors in terms of visual 
outcome improvement. 
 Results of this study is consistent with the findings 
reported by Ju-Wan Seuk as visual improvement after 
surgery in his study was seen in 83.3% and in this 
study, it was seen in 89.39%. However visual 
improvement after surgery reported by Amit Kumar 
Thotakura and Edson Rocha Constantino was quite 
low as compared to this study. i.e. (42.2% & 32.2% 
this study 89.39%). 
 According to Cohen et al. better visual acuity 
outcome was seen in patients with lesser degree of 
preoperative visual acuity compromise.21 
Gnanalingham et al. reported that the extent of the 
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visual field recovery was mainly dependent on the 
preoperative visual field deficit.7 
 Sullivan et al. in their retrospective study of 45 
patients concluded that the preoperative visual acuity 
was not predictive of postoperative visual acuity22. 
Powell in his series of 67 patients reported that 
preoperative visual defect did not correlate to the 
postoperative visual recovery.23 
 Recently in 2017 Amit Kumar Thotakura in his 
study reported no statistically significant correlation 
between the severity of preoperative visual impairment 
and the visual outcome.12 Agrawal and Mahapatra 
concluded that even if the preoperative visual 
impairment is severe, better visual outcome can be 
achieved if the duration of the symptoms is less.24 
Symon et al. reported that the degree of visual 
improvement correlated with the size of the lesion.25 
 Regarding effect of preoperative visual acuity on 
post-operative improvement in visual acuity was 
variables across the study. Cohen et al and 
Gnanalingham et al, were agreeing that with lesser 
degree of preoperative visual acuity resulted in better 
visual acuity improvement, which contradicts the 
results of this study about the effect of preoperative 
visual outcome on postoperative betterment in visual 
acuity but these findings are supported by Sullivan 
et al, Powell and Amit Kumar Thotakura.  Keeping in 
mind the above discussion it can be said that results of 
this study and results of others demonstrate that 
Endoscopic Endonasal Transsphenoidalhas good 
results withdecreased morbidity and mortality for 
treating pituitary adenoma. 
 
CONCLUSION 
Results of this study showed that pituitary gland tumor 
excision through Endoscopic Endonasal 
Transsphenoidal approach is effective in terms of 
improvement in visual acuity. As conservation and 
reinstatement of vision are main goals in pituitary 
surgery, this surgical approach has given maximum 
cover to the vision restoration in pituitary adenomas. 
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